Share this article
Share this article
DUBLIN, April 27, 2021 /PRNewswire/ The Biochips - Technologies, Markets & Companies report from Jain PharmaBiotech has been added to
ResearchAndMarkets.com s offering.
This report is an analysis of biochip/microarray markets based on technologies and applications.
The report starts with a description of technologies as a basis for the estimation of markets. Technologies include array comparative genomic hybridization (CGH), copy number variation (CNV), DNA methylation, ChIP-Chip, RNA splice variants, and microRNA. Separate chapters are devoted to protein biochips/microarrays, microfluidics, and nanobiotechnology-based nano-arrays.
Various applications of biochips and microarrays are described throughout the report. Areas of application such as point-of-care, genetic screening, cancer, and diagnosis of infections are included. Separate chapters are devoted to applications in drug discovery and development as well as personalized medic
Губернатор в Бразилии решил бороться за одобрение поставок «Спутника V» regnum.ru - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from regnum.ru Daily Mail and Mail on Sunday newspapers.
Share:
URBANA, Ill., April 26, 2021 /PRNewswire/ A team from the University of Illinois Urbana-Champaign s Grainger College of Engineering and Mayo Clinic have developed a new technique for creating microcancer cell cultures. It allows researchers to form hundreds of microcancers in a high-throughput format using a small, microfabricated chip, enabling direct measurement of cell health or response to drugs. It also allows researchers to control the shape of the culture using capillary forces and, thus, create cultures that more closely resemble
in-vivo cells three-dimensional geometry.
The work was recently published in
A cancerous tumor s microenvironment - the area where cancerous cells interact with healthy tissue through physical contact or by exchanging extracellular signals back and forth - has significant influence on how a tumor progresses and responds to cancer-fighting medications. Reproducing those cells in a culture that can be imaged and studied is a crucial
Share this article
Share this article
DUBLIN, April 26, 2021 /PRNewswire/ The DNA Sequencing - Technologies, Markets & Companies report from Jain PharmaBiotech has been added to
ResearchAndMarkets.com s offering.
This report briefly reviews basics of human genome variations, development of sequencing technologies, and their applications. Current large and small sequencers are described as well as companies developing them. Various applications of sequencing are described including those for genetics, medical diagnostics, drug discovery, and cancer. Next-generation sequencing technologies, both second and third generations, are reviewed. Companies developing software for analysis of sequencing data are also included. Selected academic institutes conducting research in sequencing are also listed.
Share this article
Share this article
ResearchAndMarkets.com s offering.
The compounding pharmacies market was valued at US$ 9,442.8 million in 2020 and is projected to reach US$ 14,995.1 million by 2028; it is expected to grow at a CAGR of 6.1% from 2021 to 2028.
Drug shortage crisis across the world, benefits associated with compounded medications, and increasing adoption of customized medicine (Personalized medicine) are among the major factors fueling the market growth. Moreover, growing demand for compounding pharmacy during COVID-19 are expected to foster the market growth during the forecast period. However, product recalls and stringent regulatory requirements hinder the growth of the compounding pharmacies market.